Choose Your Country or Region

RAD51

RAD51 Products

All (4)
RAD51 Inhibitors (3)
RAD51 Activator (1)
New RAD51 Products

Catalog No.	Product Name	Information	Product Use Citations	Product Validations
S2871	T0070907	T0070907 is a potent inhibitor of PPARγ (peroxisome proliferator activator receptor γ ) that induces G2/M arrest and enhances the effect of radiation in human cervical cancer cells through mitotic catastrophe. It also acts as an antagonist of PPARγ that suppresses breast cancer cell proliferation and motility via both PPARgamma-dependent and -independent mechanisms.	Immunity, 2024, 57(10):2344-2361.e7 Nat Commun, 2024, 15(1):1429 Bone Res, 2024, 12(1):15
S1244	Amuvatinib (MP-470)	Amuvatinib (MP-470, HPK 56) is a potent and multi-targeted inhibitor of c-Kit, PDGFRα and Flt3 with IC50 of 10 nM, 40 nM and 81 nM, respectively. Amuvatinib suppresses c-MET and c-RET. Amuvatinib is also active as a DNA repair protein Rad51 inhibitor with antineoplastic activity. Phase 2.	bioRxiv, 2024, 2023.11.21.568071 Microbiol Spectr, 2023, e0510522. J Pers Med, 2022, 12(2)258
S8077	RI-1	RI-1 (RAD51 inhibitor 1) is a RAD51 inhibitor with IC50 ranging from 5 to 30 μM.	MedComm (2020), 2024, 5(8):e690 Cell Death Discov, 2024, 10(1):434 Int J Mol Sci, 2023, 24(3)2498
S8234	RS-1	RS-1 is a RAD51-stimulatory compound, which increases the DNA binding activity of RAD51. It is an HDR(homology-directed repair) enhancer that enhances Cas9- and TALEN-mediated knock-in efficiency in rabbit embryos both in vitro and in vivo.	J Biomed Sci, 2024, 31(1):68 Int J Biol Sci, 2021, 17(4):1026-1040 Chembiochem, 2021, 22(20):2957-2965
S2871	T0070907	T0070907 is a potent inhibitor of PPARγ (peroxisome proliferator activator receptor γ ) that induces G2/M arrest and enhances the effect of radiation in human cervical cancer cells through mitotic catastrophe. It also acts as an antagonist of PPARγ that suppresses breast cancer cell proliferation and motility via both PPARgamma-dependent and -independent mechanisms.	Immunity, 2024, 57(10):2344-2361.e7 Nat Commun, 2024, 15(1):1429 Bone Res, 2024, 12(1):15
S1244	Amuvatinib (MP-470)	Amuvatinib (MP-470, HPK 56) is a potent and multi-targeted inhibitor of c-Kit, PDGFRα and Flt3 with IC50 of 10 nM, 40 nM and 81 nM, respectively. Amuvatinib suppresses c-MET and c-RET. Amuvatinib is also active as a DNA repair protein Rad51 inhibitor with antineoplastic activity. Phase 2.	bioRxiv, 2024, 2023.11.21.568071 Microbiol Spectr, 2023, e0510522. J Pers Med, 2022, 12(2)258
S8077	RI-1	RI-1 (RAD51 inhibitor 1) is a RAD51 inhibitor with IC50 ranging from 5 to 30 μM.	MedComm (2020), 2024, 5(8):e690 Cell Death Discov, 2024, 10(1):434 Int J Mol Sci, 2023, 24(3)2498
S8234	RS-1	RS-1 is a RAD51-stimulatory compound, which increases the DNA binding activity of RAD51. It is an HDR(homology-directed repair) enhancer that enhances Cas9- and TALEN-mediated knock-in efficiency in rabbit embryos both in vitro and in vivo.	J Biomed Sci, 2024, 31(1):68 Int J Biol Sci, 2021, 17(4):1026-1040 Chembiochem, 2021, 22(20):2957-2965

Choose Selective RAD51 Inhibitors

Tags: RAD51 inhibitor | RAD51 activator | RAD51 modulator